Overview:
For long-term obesity management, including weight loss, weight maintenance, together with a reduced-calorie diet, and for reducing the risk of weight regain after weight loss in patients with an initial BMI of 30kg/m² or greater. with an initial BMI of 28kg/m² or more in the presence of other risk factors ( e. g., hypertension, diabetes, dyslipidemia).
-
Orlifit acts locally within the lumen of the stomach and small intestine as a lipase inhibitor.
-
It chemically binds to gastric and pancreatic enzymes (lipases), preventing them from breaking down dietary fats (triglycerides) into absorbable fatty acids.
-
Because the undigested fats cannot be absorbed by your body, they are naturally excreted through bowel movements.
-
It effectively blocks about 30% of the fat consumed in a meal from being absorbed.
Key Indications & Uses
-
Weight Management: Used for weight loss, long-term weight maintenance, and preventing weight regain.
-
Target Audience: Typically recommended for adults with a Body Mass Index (BMI) of $30\text{ kg/m}^2$ or higher, or a BMI of $27\text{ kg/m}^2$ or higher if there are accompanying risk factors (such as type 2 diabetes, high blood pressure, or dyslipidemia).
Product Type: capsules
Pack Size: 10s
Company: Getz pharma
Used For:
How to use: You can take the capsule immediately before, during, or up to 1 hour after the meal.
